ACP issues 4 statements on T2DM treatment targets

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

In March 2018, The American College of Physicians issued 4 guidance statements on the use of hemoglobin A1c targets for nonpregnant adults with type 2 diabetes. In this audiocast, Dr. Doug Campos-Outcalt describes these statements and the ways that they differ—often significantly—from other guidelines.


Limelight Video


Qaseem A, Wilt TJ, Kansagara D, et al, for the Clinical Guidelines Committee of the American College of Physicians. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians . Ann Int Med . 2018; Mar 6. doi: 10.7326/M17-0939. [Epub ahead of print].

Next Article: